Analysis of Tumor Biomarkers with Streck® Plasma Tubes and R&D Systems™ Multiplex Panels

The integration of genomic and proteomic tools improves and fosters a deeper understanding of multicancer early detection research and diagnostic development. In large-scale cancer studies, it is important to select an appropriate sample collection material as they directly impact the reliability of biomarker detection. In this study, Streck^® plasma tubes and R&D Systems™ Human Tumor Biomarker Performance Panel, based on Luminex xMAP^® Technology, were investigated to determine the stability and sensitivity of critical analytes in a wide spectrum of tumor markers, including those associated with liver cancer, ovarian cancer, breast cancer, pancreatic cancer, neuroendocrine tumors, and thyroid cancer. This combined approach of advanced multiplex assay technology and optimized sample preservation stands to significantly enhance the precision and reproducibility of multicancer biomarker research and diagnostics.

Bio-Techne is a partner of Luminex.